Risk Factors and Pathogenic Bacteria Prevalence in Catheter-Associated Blood Stream Infection in Patients Undergoing Hemodialysis: A Cross-Sectional Study

血液透析患者导管相关血流感染的危险因素和致病菌流行情况:一项横断面研究

阅读:1

Abstract

BACKGROUND AND AIMS: Catheter-associated bloodstream infections (CABSI) cause a significant clinical and financial burden in nephrology. This study aimed to identify the clinical risk factors and prevalent pathogens associated with CABSI among hemodialysis (HD) patients at a tertiary care hospital in Pakistan. METHODS: This cross-sectional study included 150 patients (aged 18 years or older) with CABSI undergoing HD via central venous catheters (tunneled and non-tunneled) at CMH Hospital, Multan, over a 6-month period. We recorded clinical details and collected dual blood samples (catheter and peripheral vein) for culture assessment. The primary outcomes were identifying clinical risk factors and determining the prevalence of causative bacterial pathogens. RESULTS: The mean age of the sample was 61.91 ± 8.02 years, comprising 60.66% males and 39.33% females. The average duration of the catheter was 38.59 ± 18.7 days. Gram-negative bacteria (83/150, 55.33%) were more prevalent than Gram-positive bacteria (67/150, 44.66%) in these infections, with the most common pathogens being Pseudomonas aeruginosa (27/150, 18.00%) and Methicillin-resistant Staphylococcus aureus (MRSA) (25/150, 16.67%). Modifiable risk factors included prolonged catheter use (> 30 days), femoral site insertion, underlying comorbidities, and anemia. CONCLUSION: Prolonged catheter use and femoral insertion are major modifiable risk factors for CABSI in hemodialysis patients. With Gram-negative pathogens like Pseudomonas aeruginosa and MRSA predominantly responsible, targeted empirical antimicrobial strategies and early arteriovenous fistula creation are crucial to mitigate infection risks in resource-limited settings.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。